Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

Maria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, Roberto Ranza, Luis R Espinoza, Philip S Helliwell, Oliver FitzGerald, Neil McHugh, Euthalia Roussou, Philip J Mease

Research output: Contribution to journalArticle

37 Citations (Scopus)
168 Downloads (Pure)

Abstract

In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.
Original languageEnglish
Pages (from-to)2277-2285
Number of pages9
JournalThe Journal of Rheumatology
Volume41
Issue number11
DOIs
Publication statusPublished - Nov 2014

Fingerprint Dive into the research topics of 'Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review'. Together they form a unique fingerprint.

  • Cite this

    Acosta Felquer, M. L., Coates, L. C., Soriano, E. R., Ranza, R., Espinoza, L. R., Helliwell, P. S., FitzGerald, O., McHugh, N., Roussou, E., & Mease, P. J. (2014). Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review. The Journal of Rheumatology, 41(11), 2277-2285. https://doi.org/10.3899/jrheum.140876